Asymptomatic osteolysis as a risk factor for cardiovascular disease after total hip arthroplasty: A retrospective

Agata Rysinska1,2, Sara Aspberg1,3,4, Thomas Eisler1,2

  • 1Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Orthopaedics, Stockholm, Sweden.

Plos One
|December 30, 2025
PubMed

Insights

Total hip arthroplasty patients with periacetabular osteolysis showed a trend towards higher cardiovascular disease incidence. Further research is needed to confirm if peri-implant inflammation increases long-term cardiovascular disease risk after total hip arthroplasty.

Area of Science:

  • Orthopedic Surgery
  • Cardiovascular Disease Epidemiology
  • Biomaterials Science

Background:

  • Periprosthetic osteolysis, a complication of total hip arthroplasty (THA), may be linked to increased cardiovascular disease (CVD) risk.
  • Understanding this association is crucial for long-term patient management after THA.

Purpose of the Study:

  • To investigate the long-term CVD risk in THA patients with asymptomatic periacetabular osteolysis compared to those without.
  • To assess the time to CVD events and compare cardiovascular risk markers between groups.

Main Methods:

  • Retrospective cohort study of 139 patients undergoing uncemented THA (1992-2007).
  • Patients were categorized into groups with and without periacetabular osteolysis using computed tomography.
  • Kaplan-Meier and Cox regression analyses were used to evaluate time to event and hazard ratios.

Main Results:

  • A higher relative incidence of CVD was observed in patients with periacetabular osteolysis (24%) compared to those without (8%).
  • Mean follow-up was 16.6 years; 11% of patients developed CVD.
  • No significant differences in cardiovascular risk markers or ECG abnormalities were found between groups.

Conclusions:

  • The study found no direct association between periacetabular osteolysis and specific CVD risk markers.
  • A trend suggests a potential increased long-term CVD risk associated with periacetabular osteolysis following THA.
  • Low-grade peri-implant inflammation warrants further investigation as a potential contributor to increased CVD risk.
Abstract